Home > Insider Trading > Filing (0000904454-13-001302)

Filing Details

Accession Number:: 0000904454-13-001302
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-19 19:45:07
Reporting Period:: 2013-12-17

Filing Date:: 2013-12-19
Accepted Time:: 2013-12-19 19:45:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1320414	Select Medical Holdings Corp	SEM	Services-Hospitals (8060)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1123639	Welsh Carson Anderson & Stowe Ix Lp	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1212996	Sanjay Swani	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1212997	Scott D Mackesy	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1212999	Sean Traynor	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1317659	Michael Donovan	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1413863	J. Eric Lee	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-12-17	177,032	$9.95	30,240,659	No	4	S	Direct
Common Stock	Disposition	2013-12-18	382,844	$10.30	29,857,815	No	4	S	Direct
Common Stock	Disposition	2013-12-19	307,888	$10.35	29,549,927	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $10.02.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the sole general partner of the Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
Each Reporting Owner listed below also indirectly beneficially owns 1,324,167 shares of Common Stock held by WCAS Capital Partners IV, L.P. Such individuals are managing members of the sole general partner of WCAS Capital Partners IV, L.P.
Each Reporting Owner listed below also directly beneficially owns the following shares of Common Stock: Patrick J. Welsh - 518,590; Russell L. Carson - 2,222,234; Bruce K. Anderson - 1,965,630; Robert A. Minicucci - 425,679; Anthony J. deNicola -102,444 (also indirectly beneficially owns 459 shares held by deNicola Holdings LP, but disclaims beneficial ownership of such shares except tothe extent of his pecuniary interest, if any, therein and 261 shares held in trusts for the benefit of his children); Jonathan M. Rather - 33,023 (also indirectly beneficially owns 12,656 shares held by WCAS Management Corp, of which he is the controlling shareholder, but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein); Sanjay Swani - 10,731; D. Scott Mackesy - 10,691; Sean M. Traynor - 11,509; Eric J. Lee - 2,718; and Michael E. Donovan- 949.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.98 to $10.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.21 to $10.44. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.